Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C7H14O8.Tc |
Molecular Weight | 325.0875 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 5 / 5 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
[99Tc].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)[C@@H](O)C(O)=O
InChI
InChIKey=FWONYTNJVVDALD-NEXMAILDSA-N
InChI=1S/C7H14O8.Tc/c8-1-2(9)3(10)4(11)5(12)6(13)7(14)15;/h2-6,8-13H,1H2,(H,14,15);/t2-,3-,4+,5-,6-;/m1./s1/i;1+1
Molecular Formula | Tc |
Molecular Weight | 98.9063 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Molecular Formula | C7H14O8 |
Molecular Weight | 226.1813 |
Charge | 0 |
Count |
|
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 5 / 5 |
E/Z Centers | 0 |
Optical Activity | UNSPECIFIED |
DescriptionSources: https://www.hindawi.com/journals/stni/2014/839369/Curator's Comment: description was created based on several sources, including
https://www.ncbi.nlm.nih.gov/books/NBK215133/ | https://www.iaea.org/OurWork/ST/NE/NEFW/Technical-Areas/RRS/documents /mo99/WORKINGMATERIALSmo99CM.pdf | https://www.ncbi.nlm.nih.gov/pubmed/27854401
Sources: https://www.hindawi.com/journals/stni/2014/839369/
Curator's Comment: description was created based on several sources, including
https://www.ncbi.nlm.nih.gov/books/NBK215133/ | https://www.iaea.org/OurWork/ST/NE/NEFW/Technical-Areas/RRS/documents /mo99/WORKINGMATERIALSmo99CM.pdf | https://www.ncbi.nlm.nih.gov/pubmed/27854401
Molybdenum-99 (99Mo, half-life = 66 h) is a parent radionuclide of a diagnostic nuclear isotope. It decays in technetium-99 m (half-life = 6 h), which is used in over 30 million procedures per year around the world. Between 95 and 98 percent of Mo-99 is currently being produced using highly enriched uranium (HEU) targets. Other medical isotopes such as iodine-131 (I-131) and xenon-133 (Xe-133) are by-products of the Mo-99 production process and will be sufficiently available if Mo-99 is available.
Approval Year
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Diagnostic | OSTEOLITE Approved UseUnknown Launch Date1977 |
|||
Diagnostic | DRAXIMAGE MDP-10 Approved UseMDP-25 (Kit for the Preparation of Technetium Tc 99m Medronate) may be used as a bone imaging agent to delineate areas of altered osteogenesis. Launch Date1978 |
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 15:57:26 GMT 2023
by
admin
on
Fri Dec 15 15:57:26 GMT 2023
|
Record UNII |
I853LE095B
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Related Record | Type |
---|
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NDF-RT |
N0000177914
Created by
admin on Fri Dec 15 15:57:26 GMT 2023 , Edited by admin on Fri Dec 15 15:57:26 GMT 2023
|
||
|
WHO-ATC |
V09CA04
Created by
admin on Fri Dec 15 15:57:26 GMT 2023 , Edited by admin on Fri Dec 15 15:57:26 GMT 2023
|
||
|
NDF-RT |
N0000000205
Created by
admin on Fri Dec 15 15:57:26 GMT 2023 , Edited by admin on Fri Dec 15 15:57:26 GMT 2023
|
||
|
NCI_THESAURUS |
C2124
Created by
admin on Fri Dec 15 15:57:26 GMT 2023 , Edited by admin on Fri Dec 15 15:57:26 GMT 2023
|
||
|
WHO-VATC |
QV09CA04
Created by
admin on Fri Dec 15 15:57:26 GMT 2023 , Edited by admin on Fri Dec 15 15:57:26 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
100000092201
Created by
admin on Fri Dec 15 15:57:26 GMT 2023 , Edited by admin on Fri Dec 15 15:57:26 GMT 2023
|
PRIMARY | |||
|
I853LE095B
Created by
admin on Fri Dec 15 15:57:26 GMT 2023 , Edited by admin on Fri Dec 15 15:57:26 GMT 2023
|
PRIMARY | |||
|
Technetium 99mTc Glucoheptonate
Created by
admin on Fri Dec 15 15:57:26 GMT 2023 , Edited by admin on Fri Dec 15 15:57:26 GMT 2023
|
PRIMARY | |||
|
CHEMBL2110570
Created by
admin on Fri Dec 15 15:57:26 GMT 2023 , Edited by admin on Fri Dec 15 15:57:26 GMT 2023
|
PRIMARY | |||
|
C87403
Created by
admin on Fri Dec 15 15:57:26 GMT 2023 , Edited by admin on Fri Dec 15 15:57:26 GMT 2023
|
PRIMARY | |||
|
m5761
Created by
admin on Fri Dec 15 15:57:26 GMT 2023 , Edited by admin on Fri Dec 15 15:57:26 GMT 2023
|
PRIMARY | Merck Index | ||
|
49800005
Created by
admin on Fri Dec 15 15:57:26 GMT 2023 , Edited by admin on Fri Dec 15 15:57:26 GMT 2023
|
PRIMARY | |||
|
C100014
Created by
admin on Fri Dec 15 15:57:26 GMT 2023 , Edited by admin on Fri Dec 15 15:57:26 GMT 2023
|
PRIMARY | |||
|
SUB15469MIG
Created by
admin on Fri Dec 15 15:57:26 GMT 2023 , Edited by admin on Fri Dec 15 15:57:26 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
PARENT -> SALT/SOLVATE | |||
|
SUB_CONCEPT->SUBSTANCE | |||
|
PARENT -> SALT/SOLVATE |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |